Instead, C. fragrans extract induced strong and sustained activations of ERK1/2 in C6 glioblastoma cells and PC-3 prostate cancer cells, particularly strong after 24h of treatment and 1h of treatment, respectively, compared to control cells (p < 0.01) (Figures 2 and 3). This evidence concerns the gene MAPK3 and glioblastoma.